Cargando…

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease

Among patients with Parkinson’s disease (PD), depression is prevalent and disabling, impacting both health outcomes and quality of life. There is a critical need for alternative pharmacological methods to treat PD depression, as mainstream antidepressant drugs are largely ineffective in this populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanle, Brigitte, Olcott, William, Jimenez, Jaime, Bashmi, Luma, Danovitch, Itai, IsHak, Waguih William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003962/ https://www.ncbi.nlm.nih.gov/pubmed/29907742 http://dx.doi.org/10.1038/s41398-018-0162-2

Ejemplares similares

Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial
por: IsHak, Waguih William, et al.
Publicado: (2021)

The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review
por: Hedrick, Rebecca, et al.
Publicado: (2020)

Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial
por: Tashjian, Vartan C, et al.
Publicado: (2017)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
por: Bartsch, Caitlyn J., et al.
Publicado: (2022)

Virtual reality for management of pain in hospitalized patients: A randomized comparative effectiveness trial
por: Spiegel, Brennan, et al.
Publicado: (2019)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Patient-reported outcomes before and after treatment of major depressive disorder
por: IsHak, Waguih William, et al.
Publicado: (2014)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)

Contractile properties and movement behaviour in neonatal rats with axotomy, treated with the NMDA antagonist DAP5
por: Petsanis, Konstantinos, et al.
Publicado: (2012)

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans
por: Driesen, Naomi R., et al.
Publicado: (2013)

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment
por: IsHak, Waguih William, et al.
Publicado: (2016)

Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux
por: Bergstrom, Hadley C., et al.
Publicado: (2015)

Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert
por: Kulisevsky, Jaime
Publicado: (2022)

Caloric vestibular stimulation for the management of motor and non-motor symptoms in parkinson's disease: Intention-to-treat data
por: Wilkinson, David, et al.
Publicado: (2019)

Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide
por: Kuhlmann, Levin, et al.
Publicado: (2013)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Church, Frank C.
Publicado: (2021)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD
por: Lijffijt, Marijn, et al.
Publicado: (2019)

Behavioral Consequences of NMDA Antagonist-Induced Neuroapoptosis in the Infant Mouse Brain
por: Yuede, Carla M., et al.
Publicado: (2010)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015)

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review
por: Moore, Thomas J., et al.
Publicado: (2022)

The NMDA antagonist memantine affects training induced motor cortex plasticity – a study using transcranial magnetic stimulation [ISRCTN65784760]
por: Schwenkreis, Peter, et al.
Publicado: (2005)

Prodromal non-motor symptoms of Parkinson’s disease
por: Pellicano, Clelia, et al.
Publicado: (2007)

Non-Motor Off Symptoms in Parkinson's Disease
por: Cheon, Sang-Myung, et al.
Publicado: (2009)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Spectrum of Non-Motor Symptoms in Parkinson's Disease
por: Kumaresan, Maithrayie, et al.
Publicado: (2021)

Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease
por: Zhang, Yu, et al.
Publicado: (2018)

Gender differences in motor and non-motor symptoms in early Parkinson disease
por: Kang, Kyung Wook, et al.
Publicado: (2022)

Motor cortical plasticity and its correlation with motor symptoms in Parkinson's disease
por: Moriyasu, Shotaro, et al.
Publicado: (2022)

An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease
por: Lee, Hye Mi, et al.
Publicado: (2015)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
por: Skogar, Orjan, et al.
Publicado: (2018)

Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2015)

Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson’s disease
por: Choudhury, Gourav R., et al.
Publicado: (2018)

Relationship between Motor and Nonmotor Symptoms and Quality of Life in Patients with Parkinson’s Disease
por: Candel-Parra, Eduardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fhc381gdv0ftc57m96m81c1lh4